Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.07%144.07B | 15.37%144.18B | 14.47%35.05B | 9.44%36.43B | 14.75%36.03B | 23.63%36.67B | 12.80%124.96B | 8.79%30.61B | 10.25%33.29B | 18.01%31.4B |
| Cost of revenue | -1.99%108.93B | 13.93%111.14B | 10.07%26.58B | 7.03%27.95B | 15.95%28.14B | 23.70%28.47B | 13.13%97.55B | 9.09%24.15B | 10.77%26.12B | 16.88%24.27B |
| Gross profit | 6.39%35.14B | 20.50%33.03B | 30.93%8.47B | 18.22%8.47B | 10.65%7.9B | 23.38%8.2B | 11.63%27.41B | 7.69%6.47B | 8.38%7.17B | 22.02%7.14B |
| Operating expense | 14.21%21.87B | 15.55%19.14B | 40.12%5.42B | 6.39%4.6B | 5.50%4.53B | 12.54%4.6B | 14.67%16.57B | -3.71%3.87B | 20.39%4.32B | 24.68%4.29B |
| Operating profit | -4.39%13.28B | 28.06%13.89B | 17.24%3.05B | 36.19%3.88B | 18.44%3.37B | 40.68%3.6B | 7.30%10.85B | 30.75%2.6B | -5.89%2.85B | 18.22%2.84B |
| Net non-operating interest income (expenses) | -566.67%-360M | 61.15%-54M | 59.62%-21M | 168.97%20M | 116.13%5M | -114.81%-58M | -110.61%-139M | -173.68%-52M | -141.67%-29M | -63.16%-31M |
| Non-operating interest income | 125.45%372M | 371.43%165M | 408.33%61M | 488.89%53M | 280.00%38M | 225.00%13M | 20.69%35M | 9.09%12M | 12.50%9M | 66.67%10M |
| Non-operating interest expense | 117.81%477M | 25.86%219M | 28.13%82M | -13.16%33M | -19.51%33M | 129.03%71M | 83.16%174M | 113.33%64M | 90.00%38M | 64.00%41M |
| Total other finance cost | --255M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -59.13%327M | 61.62%800M | 426.76%232M | 100.41%1M | -18.75%208M | -34.85%359M | -18.45%495M | -135.15%-71M | -218.14%-241M | 158.59%256M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -70.79%614M | 2.1B | 1.3B | 0 | 0 | |||||
| Income from associates and other participating interests | 55.70%123M | -24.04%79M | 350.00%27M | 142.86%17M | -70.51%23M | -7.69%12M | 173.68%104M | -14.29%6M | 16.67%7M | 1,200.00%78M |
| Special income (charges) | -89.32%599M | 571.38%5.61B | -578.49%-823M | 172.97%27M | -102.25%-16M | 58,445.45%6.42B | 172.42%835M | 110.27%172M | 44.78%-37M | 3,191.30%711M |
| Less:Restructuring and mergern&acquisition | ---- | 118.35%20M | --20M | ---- | ---- | ---- | ---109M | --0 | ---- | ---- |
| Less:Other special charges | 90.38%-582M | -415.16%-6.05B | 238.04%381M | -118.49%-27M | 101.52%16M | -64,280.00%-6.42B | -266.88%-1.17B | -206.56%-276M | 117.91%146M | -17,666.67%-1.05B |
| Less:Write off | -104.03%-17M | -5.80%422M | 305.77%422M | ---- | ---- | --0 | -69.59%448M | -92.66%104M | --0 | 1,917.65%343M |
| Other non-operating income (expenses) | 37.77%259M | -44.38%188M | 1,100.00%70M | -94.90%16M | 66.67%40M | 785.71%62M | 348.53%338M | 97.40%-7M | 492.45%314M | 0.00%24M |
| Income before tax | -34.37%14.84B | 81.21%22.61B | 44.61%3.83B | 66.63%4.76B | -6.50%3.63B | 235.86%10.4B | 32.56%12.48B | 1,050.00%2.65B | -10.91%2.86B | 55.41%3.88B |
| Income tax | -30.91%4.73B | 84.34%6.84B | 39.06%1.06B | 62.92%1.35B | 2.60%1.11B | 219.00%3.32B | 42.69%3.71B | 841.98%763M | -4.17%828M | 44.76%1.08B |
| Net income | -35.86%10.12B | 79.89%15.77B | 46.81%2.76B | 68.19%3.42B | -9.96%2.52B | 244.37%7.07B | 28.68%8.77B | 1,163.09%1.88B | -13.43%2.03B | 59.97%2.8B |
| Net income continuous operations | -35.87%10.12B | 79.88%15.77B | 46.87%2.76B | 68.14%3.42B | -9.99%2.52B | 244.42%7.07B | 28.70%8.77B | 1,163.09%1.88B | -13.39%2.03B | 59.93%2.8B |
| Noncontrolling interests | -31.22%337M | 6.52%490M | 34.67%101M | 27.12%150M | -16.54%111M | -4.48%128M | -69.41%460M | -79.56%75M | -67.76%118M | -63.96%133M |
| Net income attributable to the company | -36.01%9.78B | 83.94%15.28B | 47.23%2.66B | 70.76%3.27B | -9.60%2.41B | 261.70%6.94B | 56.50%8.31B | 925.57%1.81B | -3.43%1.91B | 92.91%2.67B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -36.01%9.78B | 83.94%15.28B | 47.23%2.66B | 70.76%3.27B | -9.60%2.41B | 261.70%6.94B | 56.50%8.31B | 925.57%1.81B | -3.43%1.91B | 92.91%2.67B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -34.70%214.48 | 84.94%328.46 | 49.02%57.58 | 73.60%70.95 | -9.62%51.556 | 261.46%148.374 | 56.39%177.6 | 926.70%38.64 | -3.49%40.87 | 92.90%57.042 |
| Diluted earnings per share | -34.70%214.48 | 84.94%328.46 | 49.02%57.58 | 72.69%70.5793 | -9.62%51.553 | 261.46%148.374 | 56.39%177.6 | 924.97%38.64 | -3.49%40.87 | 92.90%57.042 |
| Dividend per share | 32.35%90 | 70.00%68 | 80.00%36 | 0 | 60.00%32 | 0 | 5.26%40 | 5.26%20 | 0 | 5.26%20 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |